Strep B Awareness Month

PRESS RELEASE In Recognition of Strep B Awareness Month, the European Institute of Women’s Health calls on key stakeholders and citizens of Europe to eliminate preventable Group B Strep transmission to infants 19 July 2017—July is International Group B Strep Awareness Month. This year’s theme, “What if we had known…?” promotes awareness raising of Group…

Read More

Use in pregnancy and women of childbearing age of valproate

Review of valproate use in pregnancy and women of childbearing age EMA to consider risks of these medicines require further restrictions of use The European Medicines Agency (EMA) has started a review looking at the use of valproate containing medicines in the treatment of women and girls who are pregnant or of childbearing age. These…

Read More

Final guidance for treating neuroendocrine tumours (NETs)

Guidance issued by NICE (England) for treating neuroendocrine tumours (NETs) Final guidance recommending everolimus (Infinitor, Novartis) and sunitinib (Sutent, Pfizer) to treat neuroendocrine tumours (NETs). The drugs are recommended as an option for pancreatic NETs that cannot be operated on and have progressed. Everolimus is also recommended as an option for those with NETs of…

Read More

Potential of E-health to increase vaccination coverage

Report shows potential of E-health to increase vaccination. ​Twenty one EU/EEA countries have developed or are developing systems to digitally record information about vaccination, according to a new “ECDC survey report on immunisation information systems implementation and system characteristics”. 14 of these countries already have a system in place, whereas innovative systems are being piloted…

Read More
UK flag as shield

Ixekizumab for treating moderate to severe plaque psoriasis

Today NICE, England published final draft guidance recommending Ixekizumab for treating moderate to severe plaque psoriasis.  The draft guidance can be found here Ixekizumab is recommended as an option for treating plaque psoriasis in adults, only if: the disease is severe, as defined by a total Psoriasis Area and Severity Index (PASI) of 10 or…

Read More
UK flag as shield

Tests to identify gastrointestinal pathogens

Final guidance:  tests identifying gastrointestinal pathogens Tests for people with suspected gastroenteritis Part of NICE’s diagnostics assessment programme, it does not recommend multiplex polymerase chain reaction tests (xTAG Gastrointestinal Pathogen Panel – Luminex; FilmArray Gastrointestinal Panel – BioFire Diagnostics; Faecal Pathogens B assay – AusDiagnostics) for routine use in the NHS in England. The tests…

Read More

Many to benefit from £2-a-day anti-clotting drug

Many to benefit from £2-a-day anti-clotting drug preventing heart attacks and strokes The draft guidance for ticagrelor for reducing the risk of cardiovascular events in people who have had a heart attack NICE has published draft guidance recommending anti-clotting drug ticagrelor 60 mg (Brilique, Astrazeneca) with aspirin for people who have had a heart attack….

Read More

Recommendation of secukinumab for patients with ankylosing spondylitis In draft guidance NICE,England and Wales,recommends innovative new drug secukinumab (Cosentyx, Novartis) for treating ankylosing spondylitis. Ankylosing spondylitis is a type of arthritis that mainly affects the back. Secukinumab was licensed for use in UK in May, is first in a new class of drug to treat…

Read More

Improved breast cancer treatments

Breast cancer improvement – an updated quality standard England and Wales People diagnosed with a type of early breast cancer and at risk of the cancer spreading should be offered an Oncotype DX test. This test provides information about genetic makeup of the tumour to help predict its development. This information can be used to…

Read More

In UK three diabetes treatments recommended

Three diabetes treatments recommended Three drugs can all be used on their own if a patient can’t use metformin or other specific drugs and diet and exercise alone isn’t controlling their blood glucose levels. About 3 million people in the UK have type 2 diabetes. Some 31,000 people may be eligible for the three recommended…

Read More